There is active research around YKL-40 as a biomarker in a variety of disease states. Recent studies have linked elevated YKL-40 levels to a variety of aggressive and invasive cancers, asthma and cirrhosis. A list of publications can be found in the links at the right.
Periodically we send out e-mail updates about YKL-40. If you would like to receive these, please enter your e-mail address on the right.